Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Soslow

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|October 19, 2005
Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignanciesGregory M Springett, Lynn Bonham, Amanda Hummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-upRichard R Barakat, Paul Sabbatini, Dharmendra Bhaskaran, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 21, 2018
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter StudyKala Visvanathan, Patricia Shaw, Betty J May, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry ProfilesJamie Magrill, Anthony N Karnezis, Basile Tessier-Cloutier, et al.
Cancer Causes & Control : CCC|April 26, 2008
Variants in hormone biosynthesis genes and risk of endometrial cancerSara H Olson, Irene Orlow, Sharon Bayuga, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 11, 2021
Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant PerformanceKay J Park, Isabel A Cabrero, Oluwole Fadare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical SequencingMartee L Hensley, Shweta S Chavan, David B Solit, et al.
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2022
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndromeYing L Liu, Karen A Cadoo, Anna Maio, et al.
Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|October 19, 2005
Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignanciesGregory M Springett, Lynn Bonham, Amanda Hummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-upRichard R Barakat, Paul Sabbatini, Dharmendra Bhaskaran, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 21, 2018
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter StudyKala Visvanathan, Patricia Shaw, Betty J May, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 31, 2018
Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry ProfilesJamie Magrill, Anthony N Karnezis, Basile Tessier-Cloutier, et al.
Cancer Causes & Control : CCC|April 26, 2008
Variants in hormone biosynthesis genes and risk of endometrial cancerSara H Olson, Irene Orlow, Sharon Bayuga, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 11, 2021
Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant PerformanceKay J Park, Isabel A Cabrero, Oluwole Fadare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical SequencingMartee L Hensley, Shweta S Chavan, David B Solit, et al.
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2022
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndromeYing L Liu, Karen A Cadoo, Anna Maio, et al.
Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Pageof 5